Emergent BioSolutions reported a GAAP net profit of $41.6 million for 9M 2021, down 2.9x from $119.7 million in the previous year. Revenue increased 10.1% to $1.07 billion from $0.972 billion a year earlier.
Emergent BioSolutions reported a GAAP net profit of $41.6 million for 9M 2021, down 2.9x from $119.7 million in the previous year. Revenue increased 10.1% to $1.07 billion from $0.972 billion a year earlier. 
investors.emergentbiosolutions.com
English (US) 